Skip to content
AwardedCzechiaGoodsCZK 17,928,000

Léčiva pro NEMCB (032026) - R03DX05 OMALIZUMAB

Published
Published 26 March 2026
Deadline
Closed 28 April 2026

Overview

Česká Budějovice Hospital procured continuous supplies of omalizumab (a monoclonal antibody medication for asthma treatment, ATC code R03DX05) according to operational requirements and applicable regulations. The contract was awarded to PHOENIX lékárenský velkoobchod, s.r.o. for 10,100,187.2 CZK on 27 May 2026.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 17,928,000
Procedure
Open
Published
26 March 2026
Deadline
Closed
Classification (CPV)
Medical preparations excluding dental consumables

Award outcome

Awarded value
CZK 10,100,187
Award date
27 May 2026
Contract period
1 June 2026 → 11 May 2030
Winner
  • PHOENIX lékárenský velkoobchod, s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    26 June 2026

  2. Contract Notice

    26 March 2026

Contracting authority

  • Nemocnice České Budějovice, a.s.

    Procuring entity

    České Budějovice, Czechia

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Léčiva pro NEMCB (032026) - R03DX05 OMALIZUMAB — won by PHOENIX lékárenský velkoobchod, s.r.o. — Skim